Tutogen Medical, Inc. to Present at First Albany Capital's 2nd Annual Orthopedics Conference

ALACHUA, Fla., Feb. 7  /PRNewswire-FirstCall/ -- Tutogen Medical, Inc. (AMEX:TTG), a leading manufacturer of sterile biological implant products made from human (allograft) and animal (xenograft) tissue, announced today that Guy Mayer, President and Chief Executive Officer, will be presenting at First Albany Capital's 2nd Annual Orthopedics Conference on February 13, 2007 at 2:10 p.m. Pacific time, followed by a breakout session at 2:30 p.m.  The conference is being held at the Marina Village Conference Center, 1936 Quivira Way, San Diego, California.

Investors attending the First Albany conference or the American Association of Orthopaedic Surgeons (AAOS) conference, also being held in San Diego, should contact Joe Diaz of Lytham Partners at 602-889-9700 for additional information.

About Tutogen Medical, Inc.

Tutogen Medical, Inc. manufactures sterile biological implant products made from human (allograft) and animal (xenograft) tissue.  Tutogen utilizes its Tutoplast Process(R) of tissue preservation and viral inactivation to manufacture and deliver sterile bio-implants used in spinal/trauma, urology, dental, ophthalmology, and general surgery procedures.  The Company's Tutoplast(R) products are sold and distributed worldwide by Zimmer Spine and Zimmer Dental, subsidiaries of Zimmer Holdings, Inc., Davol Inc. subsidiary of C.R. Bard Inc., the Mentor Corporation (Mentor), Coloplast Corp., IOP, Inc. and through independent distributors internationally.  For more information, visit the Company's Web site at http://www.tutogen.com/.

Forward-Looking Statement Disclaimer:  This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements typically are identified by use of terms such as "may," "will," "should," "plan," "expect," "anticipate," "estimate," and similar words, although some forward-looking statements are expressed differently.  These statements include, but are not limited to, statements made by the Company's Chief Executive Officer concerning the Company's recent financial performance and trends of quarterly revenue increases, progress toward profitability, the potential for growth in sales and continued market acceptance of the Company's hernia repair and cervical spacer products, potential growth in the Company's dental and international markets, and management's excitement about the Company's future opportunities.  Forward-looking statements are based on management's current expectations and are subject to certain risks and uncertainties that could cause actual results to differ materially from those set forth or implied by forward-looking statements.  These and other risks are identified in the Company's filings with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K for the fiscal year ended September 30, 2005, as amended.  All information in this press release is as of the date hereof, and the Company undertakes no duty to update this information unless required by law.

  Contacts:
  L. Robert Johnston, Jr.                  Lytham Partners, LLC
  Chief Financial Officer                  Joe Diaz
  Tutogen Medical, Inc.                    Joe Dorame
  386-462-0402                             Robert Blum
                      602-889-9700


DATASOURCE: Tutogen Medical, Inc.



CONTACT:  L. Robert Johnston, Jr., Chief Financial Officer of Tutogen

Medical, Inc., [phone], ; or Joe Diaz, or Joe

Dorame, or Robert Blum, all of Lytham Partners, LLC, [phone], for

Tutogen Medical, Inc.



Web site:  http://www.tutogen.com/ 

Copyright